Abstract
Bioscavenger prophylactic therapy using purified human acetylcholinesterase (AChE) or butylcholinesterase (BChE) is a promising treatment for future protection against chemical warfare nerve agent exposure. Potential immune response due to the complex structure of cholinesterases, mutations, post-translational modifications, and genetic variation is a limiting factor against purified enzyme therapy. We investigated an alternative bioscavenger approach using Forskolin, an inducer of intracellular cyclic AMP (cAMP), which activates AChE promoter and up-regulates its expression. A mouse neuronal cell line, Neuro 2A, was treated with various doses of Forskolin and analysis of the expressed enzyme indicates that the AChE activity was significantly increased in cells exposed to repeated administration of the drug every other day for 7–10 days. Cholinesterase enzyme assays showed that the enzyme activity was increased approximately 2-fold for the extracellular enzyme and 3-fold for the intracellular enzyme. The optimal dose found for extracellular enzyme production was 12–24 μM Forskolin, while the optimal dose for intracellular was 12 μM. In parallel with the rise in the AChE level, the morphology of Forskolin-treated cells showed neurite growth with increasing doses. Forskolin treatment protects Neuro 2A cells from Diisopropylflurophophate (DFP), a surrogate of the organophosphate chemical warfare agents soman and sarin, induced toxicity in Neuro 2A cells. These results indicate that transcriptional inducers, such as Forskolin, can sufficiently up-regulate cellular AChE production and protect cells against organophosphate toxicity.
Similar content being viewed by others
References
Taylor P, Wong L, Radic Z, Tsigelny I, Bruggemann R, Hosea NA, Berman HA: Analysis of cholinesterase inactivation and reactivation by systematic structural modification and enantiomeric selectivity. Chem Biol Interact 119–120: 3–15, 1999
Taylor P, Malanz S, Molles BE, Osaka H, Tsigelny I: Subunit interface selective toxins as probes of nicotinic acetylcholine receptor structure. Pflugers Arch. 440: R115–R117, 2000
Broomfield CA, Kirby SD: Progress on the road to new nerve agent treatments. J Appl Toxicol 21(Suppl 1): S43–S46, 2001
Holstege CP, Kirk M, Sidell FR: Chemical warfare. Nerve agent poisoning. Crit Care Clin 13: 923–942, 1997
LeJeune KE, Dravis BC, Yang F, Hetro AD, Doctor BP, Russell AJ: Fighting nerve agent chemical weapons with enzyme technology. Ann NY Acad Sci 864: 153–170, 1998
Doctor BP, Raveh L, Wolfe AD, Maxwell DM, Ashani Y: Enzymes as pretreatment drugs for organophosphate toxicity. Neurosci Biobehav Rev 15: 123–128, 1991
Wan DC, Choi RC, Siow NL, Tsim KW: The promoter of human acetylcholinesterase is activated by a cyclic adenosine 3′,5′-monophosphate-dependent pathway in cultured NG108-15 neuroblastoma cells. Neurosci Lett 288: 81–85, 2000
Siow NL, Choi RC, Cheng AW, Jiang JX, Wan DC, Zhu SQ, Tsim KW: A cyclic AMP-dependent pathway regulates the expression of acetylcholinesterase during myogenic differentiation of C2C12 cells. J Biol Chem 277: 36129–36136, 2002
Jiang JX, Choi RC, Siow NL, Lee HH, Wan DC, Tsim KW: Muscle induces neuronal expression of acetylcholinesterase in neuron-muscle co-culture: transcriptional regulation mediated by cAMP-dependent signaling. J Biol Chem 278: 45435–45444, 2003
Capece ML, Lydic R: cAMP and protein kinase A modulate cholinergic rapid eye movement sleep generation. Am J Physiol 273: R1430–R1440, 1997
Choi RC, Yung LY, Dong TT, Wan DC, Wong YH, Tsim KW: The calcitonin gene-related peptide-induced acetylcholinesterase synthesis in cultured chick myotubes is mediated by cyclic AMP. J Neurochem 71: 152–160, 1998
Choi RC, Siow NL, Zhu SQ, Wan DC, Wong YH, Tsim KW: The cyclic AMP-mediated expression of acetylcholinesterase in myotubes shows contrasting activation and repression between avian and mammalian enzymes. Mol Cell Neurosci 17: 732–745, 2001
Han SW, Greene ME, Pitts J, Wada RK, Sidell N: Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells. Clin Cancer Res 7: 98–104, 2001
Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, Griffin WS: Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci 20: 149–155, 2000
Kitazawa M, Yamakuni T, Song SY, Kato C, Tsuchiya R, Ishida M, Suzuki N, Adachi E, Iwashita S, Ueno S, Yanagihara N, Taoka M, Isobe T, Ohizumi Y: Intracellular cAMP controls a physical association of V-1 with CapZ in cultured mammalian endocrine cells. Biochem Biophys Res Commun 331: 181–186, 2005
Newton RA, Smit SE, Barnes CC, Pedley J, Parsons PG, Sturm RA: Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides, 2005
Rubis B, Grodecka-Gazdecka S, Lecybyl R, Ociepa M, Krozowski Z, Trzeciak WH: Contribution of protein kinase A and protein kinase C signalling pathways to the regulation of HSD11B2 expression and proliferation of MCF-7 cells. Acta Biochim Pol 51: 919–924, 2004
Sage SO, Rink TJ: Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets. FEBS Lett 188: 135–140, 1985
Rubis B, Grodecka-Gazdecka S, Lecybyl R, Ociepa M, Krozowski Z, Trzeciak WH: Contribution of protein kinase A and protein kinase C signalling pathways to the regulation of HSD11B2 expression and proliferation of MCF-7 cells. Acta Biochim Pol 51: 919–924, 2004
Ralston JS, Rush RS, Doctor BP, Wolfe AD: Acetylcholinesterase from fetal bovine serum. Purification and characterization of soluble G4 enzyme. J Biol Chem 260: 4312–4318, 1985
Ved HS, Gustow E, Pieringer RA: Regulation of neuronal differentiation in neuron-enriched primary cultures from embryonic rat cerebra by platelet activating factor and the structurally related glycerol ether lipid, dodecylglycerol. J Neurosci Res 30: 353–358, 1991
Dave JR, Koenig ML, Tortella FC, Pieringer RA, Doctor BP, Ved HS: Dodecylglycerol provides partial protection against glutamate toxicity in neuronal cultures derived from different regions of embryonic rat brain. Mol Chem Neuropathol 30: 1–13, 1997
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63, 1983
Inokoshi J, Katagiri M, Arima S, Tanaka H, Hayashi M, Kim YB, Furumai R, Yoshida M, Horinouchi S, Omura S: Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I. Biochem Biophys Res Commun 256: 372–376, 1999
Ranta T, Knecht M, Darbon JM, Baukal AJ, Catt KJ: Induction of granulosa cell differentiation by forskolin: stimulation of adenosine 3′,5′-monophosphate production, progesterone synthesis, and luteinizing hormone receptor expression. Endocrinology 114: 845–850, 1984
Vanhaecke T, Papeleu P, Elaut G, Rogiers V: Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem 11: 1629–1643, 2004
Deschenes-Furry J, Belanger G, Perrone-Bizzozero N, Jasmin BJ: Post-transcriptional regulation of acetylcholinesterase mRNAs in nerve growth factor-treated PC12 cells by the RNA-binding protein HuD. J Biol Chem 278: 5710–5717, 2003
Hubatsch DA, Jasmin BJ: Mechanical stimulation increases expression of acetylcholinesterase in cultured myotubes. Am J Physiol 273: C2002–C2009, 1997
Choi RC, Pun S, Dong TT, Wan DC, Tsim KW: NG108-15 cells induce the expression of muscular acetylcholinesterase when co-cultured with myotubes. Neurosci Lett 236: 167–170, 1997
Kuff EL, Fewell JW: Induction of neural-like cells and acetylcholinesterase activity in cultures of F9 teratocarcinoma treated with retinoic acid and dibutyryl cyclic adenosine monophosphate. Dev Biol 77: 103–115, 1980
Aoki S, Wei H, Matsui K, Rachmat R, Kobayashi M: Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis. Bioorg Med Chem 11: 1969–1973, 2003
Yang L, He HY, Zhang XJ: Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci Res 42: 261–268, 2002
Doctor BP, Blick DW, Caranto G, Castro CA, Gentry MK, Larrison R, Maxwell DM, Murphy MR, Schutz M, Waibel K: Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity. Chem Biol Interact 87: 285–293, 1993
Lee I, Salomon AR, Ficarro S, Mathes I, Lottspeich F, Grossman LI, Huttemann M: cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J Biol Chem 280: 6094–6100, 2005
Correze C, Blondeau JP, Pomerance M: p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells. Eur J Endocrinol 153: 123–133, 2005
McKay DM, Bienenstock J, Perdue MH: Inhibition of antigen-induced secretion in the rat jejunum by interferon alpha/beta. Reg Immunol 5: 53–59, 1993
Rosenblum WI: In vivo evidence that an adenylate cyclase-cAMP system dilates cerebral arterioles in mice. Stroke 19: 888–891, 1988
Voss TC, Goldman LR, Seek SL, Miller TL, Mayo KE, Somogyvari-Vigh A, Arimura A, Hurley DL: GH mRNA levels are elevated by forskolin but not GH releasing hormone in GHRH receptor-expressing MtT/S somatotroph cell line. Mol Cell Endocrinol 172: 125–134, 2001
Hansen TV, Rehfeld JF, Nielsen FC: KCl and forskolin synergistically up-regulate cholecystokinin gene expression via coordinate activation of CREB and the co-activator CBP. J Neurochem 89: 15–23, 2004
Hansen TO, Rehfeld JF, Nielsen FC: KCl potentiates forskolin-induced PC12 cell neurite outgrowth via protein kinase A and extracellular signal-regulated kinase signaling pathways. Neurosci Lett 347: 57–61, 2003
Liu R, Flammer J, Haefliger IO: Forskolin upregulation of NOS I protein expression in porcine ciliary processes: a new aspect of aqueous humor regulation. Klin Monatsbl Augenheilkd 219: 281–283, 2002
Doctor BP, Smyth KK, Gentry MK, Ashani Y, Christner CE, De La Hoz DM, Ogert RA, Smith SW: Structural and immunochemical properties of fetal bovine serum acetylcholinesterase. Prog Clin Biol Res 289: 305–316, 1989
Perez V, Bouschet T, Fernandez C, Bockaert J, Journot L: Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: A role for phosphatidylInositol 3-kinase inhibition. Eur J Neurosci 21: 26–32, 2005
Zhao AZ: Control of food intake through regulation of cAMP. Curr Top Dev Biol 67: 207–224, 2005
Johannessen M, Delghandi MP, Moens U: What turns CREB on? Cell Signal 16: 1211–1227, 2004
Reddy CS: Alterations in protein kinase A signalling and cleft palate: A review. Hum Exp Toxicol 24: 235–242, 2005
Dumaz N, Marais R: Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J 272: 3491–3504, 2005
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curtin, B.F., Pal, N., Gordon, R.K. et al. Forskolin, an inducer of cAMP, up-regulates acetylcholinesterase expression and protects against organophosphate exposure in neuro 2A cells. Mol Cell Biochem 290, 23–32 (2006). https://doi.org/10.1007/s11010-005-9084-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9084-4